<DOC>
	<DOCNO>NCT02340481</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety combine loperamide hydrochloride simethicone compare loperamide hydrochloride monotherapy treat acute diarrhea associate abdominal discomfort cause gastrointestinal gas accumulation .</brief_summary>
	<brief_title>Efficacy Safety Study Loperamide Hydrochloride/Simethicone Chewable Tablet Treatment Acute Diarrhea With Abdominal Discomfort Flatulence</brief_title>
	<detailed_description>This randomize ( study drug assign chance ) , double-blind ( neither physician participant know treatment participant receives ) , parallel-group ( group participant treat time ) , multi-center ( one hospital medical school team work medical research study ) study . All eligible participant randomly assign receive either combination loperamide hydrochloride simethicone loperamide hydrochloride . The study include Screening Visit ( -24 0 hour ) , Baseline Visit ( 0 hour ) Concluding Visit ( within 48 96 hour follow start trial ) . The timing bowel movement , stool characteristic degree duration abdominal discomfort cause gastrointestinal gas accumulation record participant 48 hour first trial drug administration . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Flatulence</mesh_term>
	<mesh_term>Loperamide</mesh_term>
	<mesh_term>Antidiarrheals</mesh_term>
	<mesh_term>Simethicone</mesh_term>
	<criteria>Participant 's symptom acute diarrhea must manifest within 48 hour prior enter trial Participant must experience least three incidence unformed stool within 24 hour prior enter trial ( refer instance watery stool soft stool determine place stool container ) Participant 's recently produce stool must unformed stool Participant must give positive answer follow question : `` Have felt abdominal discomfort cause gastrointestinal gas accumulation within last hour '' Female participant must take effective contraceptive measure throughout trial ( include oral injectable contraceptive , contraceptive tool , ligation ) postmenopausal Participant hospitalize treatment severe acute diarrhea otherwise require intravenous fluid antibiotic outpatient basis Participant show axillary temperature great ( &gt; ) 38.2 degree Celsius ( C ) oral temperature &gt; 38.6 degree C Participant show clinical symptom bloody purulent stool erythrocytes leukocyte detect participant 's stool &gt; 3 per high power field Participant show sit systolic blood pressure le ( &lt; ) 90 millimeter mercury ( mmHg ) and/ diastolic blood pressure &lt; 60 mmHg Participant unable take medication orally tolerate oral rehydration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Diarrhea</keyword>
	<keyword>Flatulence</keyword>
	<keyword>Abdominal discomfort</keyword>
	<keyword>Loperamide hydrochloride</keyword>
	<keyword>Simethicone</keyword>
	<keyword>Placebo</keyword>
</DOC>